LifeMDLFMD
About: LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Employees: 232
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
63% more call options, than puts
Call options by funds: $775K | Put options by funds: $476K
50% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 26
33% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 15
4% more funds holding
Funds holding: 100 [Q3] → 104 (+4) [Q4]
3.08% less ownership
Funds ownership: 40.03% [Q3] → 36.95% (-3.08%) [Q4]
12% less capital invested
Capital invested by funds: $90.4M [Q3] → $79.2M (-$11.2M) [Q4]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Keybanc Scott Schoenhaus 67% 1-year accuracy 24 / 36 met price target | 28%upside $7 | Overweight Maintained | 8 Jan 2025 |
Lake Street Brooks O'Neil 43% 1-year accuracy 6 / 14 met price target | 120%upside $12 | Buy Initiated | 10 Dec 2024 |
Mizuho Steven Valiquette 40% 1-year accuracy 2 / 5 met price target | 28%upside $7 | Neutral Initiated | 4 Dec 2024 |
Financial journalist opinion
